ASND
Ascendis Pharma A/S
NASDAQ Healthcare
210,45 $US
-3.83% today
-1.33% YTD · +21.61% 1Y
8
Insider transactions
SEC Form 4 · AMF · BaFin — rolling 90 days
20
Hedge funds tracked
200+ 13F SEC funds, updated quarterly
16
Thematic ETFs
ARK, NANC, GOP, GURU, BUZZ, JEPI, ITA…
24h
Frequency
Daily 5AM UTC pipeline · 2-year historical DB
53
/ 100
MIXED

Kairos Score: 53/100

Composite score aggregating 8 smart money dimensions: insiders (SEC/AMF/BaFin), hedge funds, politicians & gurus, price momentum, valuation, analyst consensus, financial health, earnings momentum. The higher the score, the more favorable the institutional signals consensus.

💡 Detailed breakdown (the 8 sub-scores) available in the Premium dashboard.

About Ascendis Pharma A/S

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing o...

Key info

👥
Employees
1 189
💰
Market cap
13 071 385 168,00 $US
📊
P/E
22.7
🚀
IPO
Jan 28, 2015

🕴️ Insider activity (90 days)

8 transactions — including 0 buys declared by Ascendis Pharma A/S executives to SEC / AMF / BaFin.

SS
SMITH SCOTT THOMAS
EVP & Chief Financial Officer · 2026-06-02
Other
BJ
BIENAIME JEAN JACQUES
2026-05-29
Other
BJ
BIENAIME JEAN JACQUES
2026-05-29
Other

🏦 Hedge Funds

20 institutional funds report a position on ASND in their latest SEC quarterly filing.

Avoro Capital Advisors LLC
FMR LLC
Artisan Partners Limited Partnership
FRANKLIN RESOURCES INC
MASSACHUSETTS FINANCIAL SERVICES CO /MA/

📰 Recent news

15 recent articles on ASND.

🧠 What makes Kairos Insider

Beyond raw data, we aggregate and score every smart money signal to give you a unique view.

🧠

Kairos Score 0-100

8-dimension composite score: insiders · hedge funds · politicians · momentum · valuation · health · analysts · earnings.

🎯

Insider Clusters

Automatic detection when 3+ executives buy the same stock simultaneously — historically the most reliable signal.

🏦

13F Hedge Funds

Berkshire (Buffett), Pershing Square (Ackman), Tiger Global, Bridgewater + 200 more. Who buys what, each quarter.

📈

ETF Rotations

NANC & GOP (Pelosi & Republicans), GURU (top hedge funds), ARK (Cathie Wood). See who enters and exits each week.

🔥

Google Trends

Spot small caps whose retail interest explodes before the rest of the market. 100+ tickers monitored.

📧

Email alerts

Create your watchlist and receive every morning at 8am the Brief of events on YOUR tickers.

Official sources · Public data · SEC EDGAR — Form 4 & 13F · AMF — Executive filings · BaFin — Directors' Dealings · Yahoo Finance · Alpha Vantage

🔓 Unlock the full analysis

This public page only shows a preview. The full analysis of ASND on the Kairos Insider dashboard includes:

✅ Full Kairos Score (8-axis radar + synthesis)
✅ History of all 8 insider transactions over 90 days
✅ All 20 hedge funds (among 200+ tracked)
✅ 11 thematic ETFs (ARK, BUZZ, NANC, GOP, JEPI…)
✅ Hot Stocks Google Trends
✅ 2-year history: AUM + rotations
✅ Fundamentals (P/E, PEG, EV/EBITDA, ROE…)
✅ Financial health (Altman Z, Piotroski F)
✅ Sector peers + 6-quarter earnings
See full analysis →
Analyze other tickers for free →

Free signup · Premium €29/month no commitment